CSBR:NASDAQ
Champions Oncology Inc
USD 4,68
arrow_downward
-0,53%(-0,025) 1D
16 Nov., 16:00:00 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CSBR...
Open
USD 4,68
High
USD 4,68
Low
USD 4,68
Mkt. cap
65,14 m
Avg. vol.
8,15 k
Volume
0,00
52-wk high
USD 8,31
52-wk low
USD 4,52
EPS
-USD 0,08
Beta
0,47
Shares outstanding
13,92 m
No. of employees
217
Open
USD 4,68
High
USD 4,68
Low
USD 4,68
Mkt. cap
65,14 m
Avg. vol.
8,15 k
Volume
0,00
52-wk high
USD 8,31
52-wk low
USD 4,52
EPS
-USD 0,08
Beta
0,47
Shares outstanding
13,92 m
No. of employees
217
News stories
From web sources and news partners
FOREX.com
·
37 minute gelede
S&P 500 forecast: Why US stocks have largely defied gravity and what could trigger a correction
Quartz
·
56 minute gelede
The Dow fell more than 700 points on Monday and the S&P 500 lost 1.9%
Benzinga
·
1 uur gelede
Shipping Stocks Rose 4.5% Last Week, Outperforming S&P 500; United Maritime Led Gains
Zawya
·
39 minute gelede
Wells Fargo sets 2027 S&P 500 target at 8,200, favors hyperscalers as AI trade matures
Profile
Champions Oncology is an American technology company that develops mouse avatars. Called TumorGrafts, they are used to test a panel of chemotherapy regimens, targeted therapies and monoclonal antibodies to identify potential therapeutic options for cancer patients. The company was founded in 2007 by David Sidransky, M.D., a Johns Hopkins University oncologist. Wikipedia
About Champions Oncology Inc
CEO-
Employees217
Founded2007
HeadquartersHackensack, New Jersey, Verenigde State van Amerika
SectorHealth Care
Industry-
Websitechampionsoncology.com